Sarah Houlton

It could be the end of the road for the UK's biotech firms if drastic action isn't taken soon.

The new EU directive looks to reduce, refine, and eventually replace animal testing

EU makes plans to police its supply chain

Will the sole-wholesaler approach mean higher costs for NHS?

Pharma defends itself against claims made in charity's report on drug access for the world's poor

One of industry's main complaints is that delaying the introduction of new medicines is a particularly simple way of saving money